[Anticoagulation in transitory ischemic attack after bypass surgery].
Bruhn
H D
HD
I. Medizinische Klinik, Klinikum der Christian-Albrechts-Universität zu Kiel.
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D003374:Coumarins / Q000008:administration & dosage / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000209:etiology* / Q000517:prevention & control; D008297:Male; D009203:Myocardial Infarction / Q000601:surgery*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*
D000925:Anticoagulants; D003374:Coumarins; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin
Antikoagulation bei transitorischen ischämischen Attacken nach Bypass-Operation.